ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022 Survival Outcomes and Characterization of Patients With mCSPC Undergoing Intensified ADT Who Do Not Achieve an Optimal PSA Response

0 views
February 24, 2022
Comments 0
Login to view comments. Click here to Login